Trading at $1.48 vs $2.61 fair value (76% upside). Transform-UTM private brand validates strategic transformation. 25% market share, 89 NPS, debt-free balance sheet.
View noteHOLD rating with $8.31 fair value. Exceptional 46.2% EBITDA margins face inevitable compression as 74% ROIC attracts competition. Income-focused opportunity only.
View noteSpark New Zealand trading at NZ$2.29 vs fair value NZ$3.07, offering 34% upside through transformation execution and defensive infrastructure advantages in dominant market position.
View noteSoul Patts trades at $38.71 vs fair value $45.81, offering 18.4% upside through portfolio evolution and private market access with 122-year dividend track record.
View noteSonic Healthcare trades at A$28.30 versus A$32.41 fair value, offering 14.5% upside through LADR integration targeting A$130m synergies with 65% achieved.
View noteIndustrial distributor trading 17% below $0.88 fair value with 16.7% ROIC and proven M&A execution across fragmented Australian market.
View noteFair value $23.50 vs current $20.00. EBITDA margins 19.1% compressing to 17.5%. Strong market positions face inevitable competitive convergence. Quality 6.75/10.
View noteTrading at $20.86 vs fair value $32.23 (+54.5% upside). EBITDA margins 18.7% vs peers 12%. Property NAV $16.73/share provides downside protection. Medium risk, favourable outlook.
View noteHOLD rating with $23.21 fair value vs $25.16 current price. Platform Unification complete, targeting 46% EBITDA margins through operational leverage amid employment recovery.
View noteHOLD rating with $2.79 fair value vs $2.57 current price. 5.8% franked yield, 4.5% alpha generation, premium NTA trading.
View noteFair value $3.22 vs current $2.94 (9.5% upside). ROIC 24.8% vs peers 9.5%. IPF integration adds scale, creates synergies.
View noteHOLD rating with A$27.36 fair value vs A$31.64 current price. Australian market leader (40%+ share) facing transformation execution risks and European margin pressure.
View note